DR. REDDY’S LABORATORIES LIMITED (RDY) Financial Statements
DR. REDDY’S LABORATORIES LIMITED (RDY) files with the U.S. Securities and Exchange Commission under CIK 0001135951. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2026
- Revenue
- 335.93 billion INR
- Net Income
- 42.47 billion INR
- Total Assets
- 579.35 billion INR
- Net Cash from Operations
- 56.76 billion INR
Fiscal year ended Mar 31, 2026. Latest periodic SEC filing: May 29, 2026. Source: SEC filings (EDGAR XBRL). Amounts in INR.
Open the full financial statements for RDY in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History